This report provides an overview of the US immunodiagnostics market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays.
Table of Contents
Business Environment
1. Health Care Expenditures
2. Cost Consciousness
3. Industry Consolidation
4. Managed Care
5. Hospitals
6. Admissions
7. Length of Stay
8. Industry Diversification
9. Physician Demographics
10. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
11. Laboratory Regulations
Market Structure
1. Centralized Testing
a. Hospitals
b. Commercial/Private Laboratories
2. Decentralized Testing
a. Physician Offices/Group Practices
b. Point-of-Care Testing
c. Home/Self Testing
d. Other Decentralized Testing Locations
Market Size, Growth, Major Suppliers
Instrument and Reagent Sales and Market Shares
List of Tables
Clinical Chemistry and Immunodiagnostic
Volume Forecasts By Test Category
Clinical Chemistry and Immunodiagnostic
Reagent Sales Forecasts By Test Category
Clinical Chemistry and Immunodiagnostic
Instrument Sales Forecasts By Analyzer Type
Estimated Sales and Market Shares of Major Suppliers
Of Clinical Chemistry Instruments and Reagents
Estimated Sales and Major Shares of Major Suppliers
Of Immunodiagnostic Instruments and Reagents
Contains 35 pages and 5 tables